---

Dendrimer evolution timeline: Ground-breaking progress in cancer treatment

---

Guest Editorial

Author Details : Sankha Bhattacharya*, Utkarsha Chhotulal Kuwar

Volume : 8, Issue : 3, Year : 2021

Article Page : 179-181

https://doi.org/10.18231/j.ijpp.2021.030

Suggest article by email

Get Permission

---

Abstract

Dendrimers holds potential in abating restrictions of other available treatments through the development of functionalized particles for targeted treatment. By developing functionalized particles for targeted treatment, dendrimers have the ability to reduce the limitations of other available therapies. Dendrimers have many advantages over other nanoparticles, making them perfect candidates for more efficient and targeted drug delivery. Dendrimers have the ability to deliver vast quantities of drugs to particular locations. They can also be used to monitor the progress of the procedure, giving them a theranostic capability that has never been seen before. Dendrimers show their potential applicability for effective cancer treatment for the near future. These article highlights the evolution timeline of dendrimers and various related aspects of the past four decades. These also involve the basic structure and information of dendrimers along with the current and future perspective. As a result, it is important to study dendrimers in order to keep up with recent developments.

Keywords: Dendrimers, PAMAM dendrimer, Theranostic agents, Polyphenylene dendrimers, Encapsulation, Drug delivery system

How to cite : Bhattacharya S, Kuwar U C, Dendrimer evolution timeline: Ground-breaking progress in cancer treatment. Indian J Pharm Pharmacol 2021;8(3):179-181

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.